Modeling of release position and ventilation effects on olfactory aerosol drug delivery

Direct nose-to-brain drug delivery has multiple advantages over conventional intravenous deliveries. However, demonstration of its clinical feasibility is still in adolescence due to the lack of devices that effectively deliver medications to olfactory epitheliums. The objective of this study is to numerically evaluate two olfactory delivery protocols in a MRI-based nasal airway model: (1) pointed drug release in the vestibule (i.e., vestibular intubation), and (2) deep intubation with mediation released close to the olfactory mucosa. Influences of breathing maneuvers on olfactory delivery were also studied. It was observed that the front vestibular release gave higher olfactory dosage than the posterior vestibular release, and deep intubations yielded better outcomes than vestibular intubations. Specifically, the optimal olfactory dosage was achieved with deep intubation during inhalation. Breath-holding or exhalation, which was initially considered advantageous, resulted in unfocused depositions throughout the nasal turbinate region. Results of this study have implications for developing new olfactory delivery devices and for optimizing delivery protocols specific to patients' ventilations.

[1]  M. M. Mozell,et al.  Numerical simulation of airflow in the human nasal cavity. , 1995, Journal of biomechanical engineering.

[2]  P. Longest,et al.  Numerical and experimental deposition of fine respiratory aerosols: Development of a two-phase drift flux model with near-wall velocity corrections , 2008 .

[3]  Jinhee Jeong,et al.  On the identification of a vortex , 1995, Journal of Fluid Mechanics.

[4]  Seung-Kyu Chung,et al.  Digital particle image velocimetry studies of nasal airflow , 2008, Respiratory Physiology & Neurobiology.

[5]  M. Manninen,et al.  On the mixture model for multiphase flow , 1996 .

[6]  Sandip S Chavhan,et al.  Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route , 2011, Journal of drug targeting.

[7]  J. Kreuter,et al.  Application of nanoparticles for the delivery of drugs to the brain , 2005 .

[8]  M. Nireekshan Kumar,et al.  Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[9]  R. Thorne,et al.  Delivery of 125I-NGF to the Brain via the Olfactory Route , 1997 .

[10]  William L. Roberts,et al.  A new methodology for targeting drug-aerosols in the human respiratory system , 2008 .

[11]  D A Smith,et al.  The effect of molecular size on the nasal absorption of water‐soluble compounds in the albino rat , 1987, The Journal of pharmacy and pharmacology.

[12]  Jinxiang Xi,et al.  Simulation of airflow and aerosol deposition in the nasal cavity of a 5-year-old child , 2011 .

[13]  Lisbeth Illum,et al.  Nanoparticles for direct nose-to-brain delivery of drugs. , 2009, International journal of pharmaceutics.

[14]  Julia S. Kimbell,et al.  Particle Deposition in Human Nasal Airway Replicas Manufactured by Different Methods. Part I: Inertial Regime Particles , 2004 .

[15]  Raymond A. Guilmette,et al.  Morphometry of Human Nasal Airways In Vivo Using Magnetic Resonance Imaging , 1989 .

[16]  A. Misra,et al.  Drug delivery to the central nervous system: a review. , 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[17]  Lucienne Juillerat-Jeanneret,et al.  The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? , 2008, Drug discovery today.

[18]  Samir Vinchurkar,et al.  Validating CFD predictions of respiratory aerosol deposition: effects of upstream transition and turbulence. , 2007, Journal of biomechanics.

[19]  Jeffry D Schroeter,et al.  Analysis of particle deposition in the turbinate and olfactory regions using a human nasal computational fluid dynamics model. , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[20]  Jiyuan Tu,et al.  Numerical simulations for detailed airflow dynamics in a human nasal cavity , 2008, Respiratory Physiology & Neurobiology.

[21]  E. Bechgaard,et al.  A microdialysis model to examine nasal drug delivery and olfactory absorption in rats using lidocaine hydrochloride as a model drug. , 2004, International journal of pharmaceutics.

[22]  C Kleinstreuer,et al.  Targeted drug-aerosol delivery in the human respiratory system. , 2008, Annual review of biomedical engineering.

[23]  Guilherme J M Garcia,et al.  Toward personalized nasal surgery using computational fluid dynamics. , 2011, Archives of facial plastic surgery.

[24]  G. Mustafa,et al.  Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study , 2012, International journal of nanomedicine.

[25]  Junjie Gu,et al.  Numerical simulation of aerosol deposition in a 3-D human nasal cavity using RANS, RANS/EIM, and LES , 2007 .

[26]  A. Misra,et al.  Drug delivery systems from nose to brain. , 2012, Current pharmaceutical biotechnology.

[27]  L. Hanson,et al.  Strategies for Intranasal Delivery of Therapeutics for the Prevention and Treatment of NeuroAIDS , 2007, Journal of Neuroimmune Pharmacology.

[28]  Jinxiang Xi,et al.  Effectiveness of Direct Lagrangian Tracking Models for Simulating Nanoparticle Deposition in the Upper Airways , 2007 .

[29]  Clement Kleinstreuer,et al.  Modeling of inertial particle transport and deposition in human nasal cavities with wall roughness , 2007 .

[30]  L. Illum.  Nasal drug delivery: new developments and strategies. , 2002, Drug discovery today.

[31]  L. Illum.  Transport of drugs from the nasal cavity to the central nervous system. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[32]  W. Frey,et al.  Intranasal administration of insulin-like growth factor-I bypasses the blood–brain barrier and protects against focal cerebral ischemic damage , 2001, Journal of the Neurological Sciences.

[33]  Goodarz Ahmadi,et al.  Airflow and Deposition of Nano-Particles in a Human Nasal Cavity , 2006 .

[34]  X. Baur,et al.  Increased Incidence of DNA Double-Strand Breaks in Lung and Liver of Rats After Exposure to Crocidolite Asbestos Fibers , 1994 .

[35]  Jinxiang Xi,et al.  Characterization of Submicrometer Aerosol Deposition in Extrathoracic Airways during Nasal Exhalation , 2009 .

[36]  P. Longest,et al.  Evaluation of a Drift Flux Model for Simulating Submicrometer Aerosol Dynamics in Human Upper Tracheobronchial Airways , 2008, Annals of Biomedical Engineering.

[37]  Jinxiang Xi,et al.  Transport and Deposition of Micro-Aerosols in Realistic and Simplified Models of the Oral Airway , 2007, Annals of Biomedical Engineering.

[38]  R. Eccles,et al.  A role for the nasal cycle in respiratory defence. , 1996, The European respiratory journal.

[39]  W. Finlay,et al.  Improved numerical simulation of aerosol deposition in an idealized mouth-throat , 2004 .

[40]  H. Steinbusch,et al.  Delivery of peptide and protein drugs over the blood–brain barrier , 2009, Progress in Neurobiology.

[41]  A S Wexler,et al.  Detailed flow patterns in the nasal cavity. , 2000, Journal of applied physiology.

[42]  P. Dalton,et al.  Effect of anatomy on human nasal air flow and odorant transport patterns: implications for olfaction. , 2004, Chemical senses.

[43]  Jan Born,et al.  Sniffing neuropeptides: a transnasal approach to the human brain , 2002, Nature Neuroscience.

[44]  David L. Swift,et al.  Deposition of Ultrafine Aerosols in the Head Airways During Natural Breathing and During Simulated Breath Holding Using Replicate Human Upper Airway Casts , 1995 .

[45]  D. Porte,et al.  Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. , 1987, The Journal of clinical endocrinology and metabolism.

[46]  Gabriel A Silva,et al.  Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier. , 2007, Surgical neurology.

[47]  M. Schwartz,et al.  Progress in the search for neuronal mechanisms coupling type 2 diabetes to obesity. , 2001, The Journal of clinical investigation.

[48]  R. C. Schroter,et al.  Mechanics of airflow in the human nasal airways , 2008, Respiratory Physiology & Neurobiology.

[49]  Grace M. Kepler,et al.  Effects of Differences in Nasal Anatomy on Airflow Distribution: A Comparison of Four Individuals at Rest , 2008, Annals of Biomedical Engineering.

[50]  Jinxiang Xi,et al.  Numerical predictions of submicrometer aerosol deposition in the nasal cavity using a novel drift flux approach , 2008 .

[51]  B. Laube,et al.  Devices for aerosol delivery to treat sinusitis. , 2007, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[52]  C Kleinstreuer,et al.  Laminar airflow and nanoparticle or vapor deposition in a human nasal cavity model. , 2006, Journal of biomechanical engineering.

[53]  D. Wilcox.  Turbulence modeling for CFD , 1993 .

[54]  P. Longest,et al.  Effects of oral airway geometry characteristics on the diffusional deposition of inhaled nanoparticles. , 2008, Journal of biomechanical engineering.

[55]  K. Sawant,et al.  Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. , 2011, Acta biomaterialia.

[56]  T. Davidson,et al.  The Nasal Valve: A Review of the Anatomy, Imaging, and Physiology , 2004, American journal of rhinology.

[57]  D. Zochodne,et al.  Intranasal Insulin Ameliorates Experimental Diabetic Neuropathy , 2009, Diabetes.

[58]  Xin-guo Jiang,et al.  Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations , 2012, Journal of drug targeting.